Trastuzumab and Nivolumab Combo Shows Encouraging Response in HER2-Positive Biliary Tract Cancer
Developing · 1 item · 1 language ninjs package →first 22.09.2026 12:02 · last 22.09.2026 12:02 UTC
| Time | Lang | Type | Headline | Desk | Rights |
|---|---|---|---|---|---|
| 22.09 12:02 | en | Standard story | Trastuzumab and Nivolumab Combo Shows Encouraging Response in HER2-Positive Biliary Tract Cancer | Science Official | link only |